Thursday, June 13, 2013
Boston researchers have discovered a blood-borne protein, growth differentiation factor 11, that
can reverse age-related cardiac hypertrophy in mice.1 The protein
could be used as a therapeutic agent once its long-term effects are understood.
Osherovich, L. SciBX 6(23); doi:10.1038/scibx.2013.567 Published online June
1. Loffredo, F.S. et
al. Cell; published online May 9, 2013; doi:10.1016/j.cell.2013.04.015 Contact:
Richard T. Lee, Brigham and Women's Hospital, Boston, Mass. e-mail: firstname.lastname@example.org
Contact: Amy J. Wagers, Harvard University, Cambridge, Mass. e-mail: email@example.com
AND INSTITUTIONS MENTIONED
Acceleron Pharma Inc., Cambridge, Mass.
Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif.
Brigham and Women's Hospital, Boston, Mass.
Harvard Medical School, Boston, Mass.
Harvard University, Cambridge, Mass.
Howard Hughes Medical Institute, Chevy Chase, Md.
(LSE:SHP; NASDAQ:SHPG), Dublin, Ireland
The University of Texas Southwestern Medical Center, Dallas, Texas
University of Medicine and Dentistry of New Jersey, Newark, N.J.